In contexts where high BK current densities in striatal cholinergic neurons are associated with hyperexcitability of cholinergic neurons, the novel CDK5 activator may provide an intervention target to suppress dyskinesia-like behaviors in neurological disorders. Here, CDK5 is linked to Dyskinesia.